🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06334549
Recruiting Phase 4

A Prospective Study of Vasopressor on Cerebral Oxygenation During General Anesthesia

NCT06334549 · tracked via the Priya Life Science China tracker
Sponsor
Dalian Municipal Central Hospital
Phase
Phase 4
Started
2024-03-05
Last updated
2024-11-06

Condition(s) studied

Hypotension Drug-Induced

Investigational drug(s) / intervention(s)

Ephedrine-PPhenylephrine-PNorepinephrine-PEphedrine-SPhenylephrine-SNorepinephrine-S

Ephedrine-P: after induction of anesthesia, use total intravenous anesthesia maintained with propofol

Phenylephrine-P: after induction of anesthesia, use total intravenous anesthesia maintained with propofol

Norepinephrine-P: after induction of anesthesia, use total intravenous anesthesia maintained with propofol

Ephedrine-S: after induction of anesthesia, use inhalation anesthesia maintained with sevoflurane

Phenylephrine-S: after induction of anesthesia, use inhalation anesthesia maintained with sevoflurane

Norepinephrine-S: after induction of anesthesia, use inhalation anesthesia maintained with sevoflurane

Study summary

The purpose of this study is to investigate whether norepinephrine(N), phenylephrine(P) or ephedrine(E) have different effect on cerebral oxygenation in abdominal surgery with propofol or sevoflurane.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * ASA I-III, age 18-80 years * Elective abdominal surgery * Signed informed consent Exclusion Criteria: * ASA≥IV * Preoperative unstable blood hemodynamics * Allergy to ephedrine, phenylephrine or norepinephrine * Decrease in MAP \<20% * Severe cardiovascular disorder

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Dalian Municipal Central Hospital Dalian Liaoning Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06334549 on ClinicalTrials.gov ↗ ← All trials in China